Company: Iovance Biotherapeutics, Inc.

The Company Iovance Biotherapeutics, Inc. (NASDAQ:IOVA), is a commercial-stage oncology company and the global leader in innovating, developing, and delivering tumor infiltrating lymphocyte (TIL) therapies for patients with cancer by harnessing the human immune system’s ability to recognize and destroy diverse cancer cells in each patient. The company’s proprietary tumor infiltrating lymphocyte (TIL) therapies use [...]Read More... from General Manager – Europe See details